AI Article Synopsis
- The review focuses on five drugs—propofol, fentanyl, rocuronium, sugammadex, and dexamethasone—used for anesthesia induction and pain management in cancer patients.
- Despite their safety in practice, the exact mechanisms of these agents in inducing anesthesia remain unclear, and studies suggest a potential link between anesthetic use and cancer progression.
- The review emphasizes the importance of understanding drug effects in cancer treatments and utilizes in silico tools to assess drug interactions and effectiveness across different patient subgroups.
Article Abstract
In this review, we aim to discuss the use and effect of five different drugs used in the induction of anesthesia in cancer patients. Propofol, fentanyl, rocuronium, sugammadex, and dexamethasone are commonly used to induce anesthesia and prevent pain during surgery. Currently, the mechanisms of these drugs to induce the state of anesthesia are not yet fully understood, despite their use being considered safe. An association between anesthetic agents and cancer progression has been determined; therefore, it is essential to recognize the effects of all agents during cancer treatment and to evaluate whether the treatment provided to the patients could be more precise. We also highlight the use of in silico tools to review drug interaction effects and safety, as well as the efficacy of the treatment used according to different subgroups of patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695346 | PMC |
| http://dx.doi.org/10.3390/jpm12111846 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!